Correction To: Analysis of Autonomic Outcomes in APOLLO, a Phase III Trial of the RNAi Therapeutic Patisiran in Patients With Hereditary Transthyretin-Mediated Amyloidosis

Journal of Neurology - Germany
doi 10.1007/s00415-020-09715-5

Related search